US 11197932
Polymer-drug conjugates for combination anticancer therapy
granted A61KA61K31/4745A61K31/704
Quick answer
US patent 11197932 (Polymer-drug conjugates for combination anticancer therapy) held by The Regents of the University of California expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/4745, A61K31/704, A61K31/7068, A61K47/61